InSilico Medicine Cayman TopCo (HKG:3696)

HKG:3696 Statistics

Total Valuation

HKG:3696 has a market cap or net worth of HKD 32.65 billion. The enterprise value is 31.03 billion.

Market Cap	32.65B
Enterprise Value	31.03B

Important Dates

The next confirmed earnings date is Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:3696 has 570.75 million shares outstanding. The number of shares has increased by 14.36% in one year.

Current Share Class	570.75M
Shares Outstanding	570.75M
Shares Change (YoY)	+14.36%
Shares Change (QoQ)	+1.52%
Owned by Insiders (%)	7.80%
Owned by Institutions (%)	45.31%
Float	366.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	77.59
PB Ratio	-6.10
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-89.15
EV / Sales	73.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-63.01

Financial Position

The company has a current ratio of 0.25

Current Ratio	0.25
Quick Ratio	0.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.11
Interest Coverage	-404.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	9.20%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:3696 has paid 1.18 million in taxes.

Income Tax	1.18M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	60.73
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.74
Average Volume (20 Days)	2,793,718

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:3696 had revenue of HKD 420.77 million and -348.07 million in losses. Loss per share was -4.68.

Revenue	420.77M
Gross Profit	351.60M
Operating Income	-488.41M
Pretax Income	-346.90M
Net Income	-348.07M
EBITDA	-460.31M
EBIT	-488.41M
Loss Per Share	-4.68

Balance Sheet

The company has 1.67 billion in cash and 54.52 million in debt, with a net cash position of 1.61 billion or 2.83 per share.

Cash & Cash Equivalents	1.67B
Total Debt	54.52M
Net Cash	1.61B
Net Cash Per Share	2.83
Equity (Book Value)	-5.35B
Book Value Per Share	-69.22
Working Capital	-5.43B

Cash Flow

In the last 12 months, operating cash flow was -485.64 million and capital expenditures -6.85 million, giving a free cash flow of -492.49 million.

Operating Cash Flow	-485.64M
Capital Expenditures	-6.85M
Depreciation & Amortization	28.02M
Net Borrowing	-13.50M
Free Cash Flow	-492.49M
FCF Per Share	-0.86

Margins

Gross margin is 83.56%, with operating and profit margins of -116.08% and -82.72%.

Gross Margin	83.56%
Operating Margin	-116.08%
Pretax Margin	-82.44%
Profit Margin	-82.72%
EBITDA Margin	-109.40%
EBIT Margin	-116.08%
FCF Margin	n/a

Dividends & Yields

HKG:3696 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.36%
Shareholder Yield	-14.36%
Earnings Yield	-1.07%
FCF Yield	-1.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:3696 has an Altman Z-Score of -8.13 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.13
Piotroski F-Score	1